Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00814151 Completed - Sepsis Clinical Trials

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

Start date: July 2008
Phase: N/A
Study type: Observational

In-vitro identification of S. aureus, methicillin-sensitive S. aureus (MSSA), and methicillin-resistant S. aureus (MRSA) from positive blood cultures by MicroPhage's bacteriophage-based diagnostic platform.

NCT ID: NCT00813501 Terminated - Lymphoma Clinical Trials

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Start date: June 2008
Phase: N/A
Study type: Observational

RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment. PURPOSE: This clinical trial is studying an immunologic diagnostic blood test to see how well it works in predicting side-effects in patients with hematologic cancer or other disorders who have undergone a donor stem cell transplant.

NCT ID: NCT00812747 Completed - Clinical trials for Surgical Wound Infection

Surgical Wound Infections After Vascular Surgery: Prospective Multicenter Trial

Start date: June 2007
Phase: N/A
Study type: Observational

The purpose of this multicentre prospective trial is to determine the incidence and risk factors for surgical wound infections. Also the investigators will evaluate consequences of wound infections to the patients, and extra costs caused by wound infections.

NCT ID: NCT00812448 Completed - Influenza Infection Clinical Trials

Catechin Containing Mask for the Prevention of Influenza Infection

Start date: December 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of catechin extracts containing mask on prevention of influenza infection.

NCT ID: NCT00812422 Completed - Fever Clinical Trials

The Efficacy and Safety of Dexibuprofen Syrup

Start date: February 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of dexibuprofen syrup and ibuprofen syrup in patients with fever due to common cold.

NCT ID: NCT00812318 Completed - HIV Infection Clinical Trials

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Start date: June 2008
Phase: Phase 1
Study type: Interventional

To evaluate the single dose relative bioavailability of GSK1265744 10mg administered in either oral solution fasted, two 5mg tablets fasted, or two 5mg tablets following a moderate meal.

NCT ID: NCT00811642 Completed - Fungal Infection Clinical Trials

Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this multicenter, open label study, is to evaluate the safety and efficacy of a 12-week treatment with Posaconazole Oral Suspension in participants with IFI

NCT ID: NCT00811603 Completed - Infection Clinical Trials

Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the rates of maternal and neonatal infectious morbidity in gravid patients undergoing cesarean delivery. Specifically, the investigators are examining whether the timing of antibiotic administration has any effect on rates of maternal and neonatal infections, neonatal sepsis work-up and length of hospital stay.

NCT ID: NCT00810446 Completed - Tuberculosis Clinical Trials

Safety And Efficacy Of Rifabutin In HIV Patients

Start date: June 2009
Phase:
Study type: Observational

The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy of this drug.

NCT ID: NCT00809913 Completed - Clinical trials for Urinary Tract Infection

Febrile Urinary Tract Infection Randomized Short Treatment Trial

FUTIRST
Start date: December 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a 7-day duration of antibiotic treatment of febrile urinary tract infection (FUTI) is non inferior to 14-day standard duration of treatment in unselected population presenting at primary care or emergency department.